Clinical Trials Directory

Trials / Unknown

UnknownNCT04493112

SeQuent Please Neo Multicenter Registry

SeQuent Please Neo Multicenter Registry / Registro Multicéntrico Sequent Please NEO

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Germans Trias i Pujol Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The registry evaluates the safety and efficacy of paclitaxel-releasing SeQuent® Please Neo balloon in the following scenarios: restenosis, bifurcation lesions, small vessel lesions, diabetes (diffuse disease) and atrial fibrillation. The objective is to determine the success of the procedure and the preservation of vascular permeability.

Detailed description

The preset registry aim is to evaluate the safety and efficacy of paclitaxel-releasing SeQuent® Please Neo balloon in the following scenarios: restenosis, bifurcation lesions, small vessel lesions, diabetes (diffuse disease) and atrial fibrillation. The principal objective is to determine the success of the procedure and the preservation of vascular permeability.

Conditions

Timeline

Start date
2018-10-05
Primary completion
2021-12-31
Completion
2021-12-31
First posted
2020-07-30
Last updated
2020-07-30

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04493112. Inclusion in this directory is not an endorsement.

SeQuent Please Neo Multicenter Registry (NCT04493112) · Clinical Trials Directory